Compare Ascendis Pharma A/S (ASND) vs Strategy Inc. (MSTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Strategy Inc. — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Strategy Inc. trades at $97.66 (market cap $37.84B). The key difference: Strategy Inc. is far larger — about 2.3× Ascendis Pharma A/S's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Strategy Inc. nearer its low. Which is the better fit depends on your goals.
| ASND | MSTR | |
|---|---|---|
Market Cap | $16.67B | $37.84B |
Sector | Health | Technology |
52-Week High | $277.18 | $394.39 |
52-Week Low | $189.74 | $82.31 |
Enterprise Value | $17.04B | $56.61B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →
